Equity / Investment · GCC · Announced 1 Nov 2026
Al Badr Trading & Industry, Lamaa Pharma, Al Mansoor + 1 other → Khazaen Economic City
Oman's Khazaen Economic City signed four investment agreements worth OMR 20 million (about US$52 million) for three pharmaceutical plants, covering oral solids, oncology, immunology and anaesthesia, plus a medical storage centre.
Parties: Al Badr Trading & Industry, Lamaa Pharma, Al Mansoor + 1 other → Khazaen Economic City (Oman)
- Deal type
- Equity / Investment
- Value
- $52m
- Territory
- Oman – Khazaen Economic City
- Therapeutic area
- Multi-therapy
- Asset
- Three pharmaceutical plants and a medical storage centre
- Announced
- 1 Nov 2026
Our analysis
Why this matters
Khazaen Economic City in Oman has signed four investment agreements worth OMR 20 million in total, covering more than 52,000 m². Al Badr Trading and Industry will invest OMR 7 million in a tablets and capsules plant; Lamaa Pharmaceutical OMR 6 million in a plant for oncology, immunology and anaesthesia drugs; Al Mansoor Pharmaceutical Factory OMR 5 million in a plant for human medicines and vitamins; and National Pharmacy OMR 2 million in a storage and logistics centre of about 29,000 m² for medicines, devices and supplies.
The agreements were announced on 1 November at a meeting held under the patronage of Oman's Minister of Health, alongside the launch of specialised pharmaceutical and medical-device clusters totalling 1.5 million m² across Salalah Free Zone, Raysut Industrial City and Khazaen. Incentives include tax exemptions of up to 30 years, land rights of up to 50 years and 100% foreign ownership.
The full analysis is free to read with a work email on this page.
Source: Wa-gulf (Oman)